Polymorphic variants of the IL2RA gene and susceptibility to type 1 diabetes in the Polish population

Tissue Antigens

Volumn 79, Issue 3, 2012, Pages 198-203

  Fichna, M ^a,b   Zurawek, M ^a   Fichna, P ^b   Januszkiewicz, D ^a,b   Nowak, J ^a  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

IL2RA gene; Single nucleotide polymorphism; Type 1 diabetes

Indexed keywords

INTERLEUKIN 2 RECEPTOR ALPHA;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE LOCUS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; POLAND; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; INFANT; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; POLAND; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84856597584     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2011.01828.x     Document Type: Article

References (42)

1. Todd JA. Etiology of type 1 diabetes. Immunity 2010: 32: 457-67.
2. Wellcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 2007: 447: 661-78.
3. Smyth DJ, Cooper JD, Bailey R et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 2006: 38: 617-9.
4. Barrett JC, Clayton DG, Concannon P et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009: 41: 703-7.
5. Wang X, Rickert M, Garcia KC. Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors. Science 2005: 310: 1159-63.
6. Malek TR, Yu A, Zhu L, Matsutani T, Adeegbe D, Bayer AL. IL-2 family of cytokines in T regulatory cell development and homeostasis. J Clin Immunol 2008: 28: 635-9.
7. Kuniyasu Y, Takahashi T, Itoh M, Shimizu J, Toda G, Sakaguchi S. Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int Immunol 2000: 12: 1145-55.
8. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW. Interelukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995: 3: 521-30.
9. Sharfe N, Dadi HK, Shshar M, Roifman CM. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci USA 1997: 94: 3168-71.
10. Caudy AA, Reddy ST, Chatila T, Atkinson JP, Verbsky JW. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enetropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol 2007: 119: 482-7.
11. Vella A, Cooper JD, Lowe CE et al. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 2005: 76: 773-9.
12. International Multiple Sclerosis Genetics Consortium; Hafler DA, Compston A, Sawcer S et al. Risk alleles for multiple sclerosis identified by a genome wide study. N Engl J Med 2007: 357: 851-62.
13. Stahl EA, Raychudhuri S, Remmers EF et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010: 42: 508-14.
14. Lowe CE, Cooper JD, Brusko T et al. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Net Genet 2007: 39: 1074-82.
15. Brand OJ, Lowe CE, Heward JM et al. Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin Endocrinol (Oxf) 2007: 66: 508-12.
16. Carr EJ, Clatworthy MR, Lowe CE et al. Contrasting genetic association of IL2RA with SLE and ANCA-associated vasculitis. BMC Med Genet 2009: 10: 22.
17. Hinks A, Ke X, Barton A et al. Association of the IL2RA/CD25 gene with juvenile idiopathic arthritis. Arthritis Rheum 2009: 60: 251-7.
18. Maier LM, Lowe CE, Cooper J et al. IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genet 2009: 5: e1000322.
19. Qu HQ, Montpetit A, Ge B, Hudson TJ, Polychronakos C. Toward further mapping of the association between the IL2RA locus and type 1 diabetes. Diabetes 2007: 56: 1174-6.
20. Skinningsrud B, Husebye ES, Pearce SH et al. Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency. J Clin Endocrinol Metab 2008: 93: 3310-7.
21. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualisation of LD and haplotype maps. Bioinformatics 2005: 21: 263-5.
22. Zurawek M, Fichna M, Fichna P, Januszkiewicz D, Nowak J. No evidence for association of the polymorphisms in NLPR1 gene with type 1 diabetes in Poland. Diabetes Res Clin Pract 2011: 92: e49-51.
23. Fichna M, Zurawek M, Januszkiewicz-Lewandowska D, Fichna P, Nowak J. PTPN22, PDCD1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Polish patients. Int J Immunogenet 2010: 37: 367-72.
24. Howson JM, Walker NM, Smyth DJ, Todd JA. Type I Diabetes Genetics Consortium. Analysis of 19 genes for association with type I diabetes in the Type I Diabetes Genetics Consortium families. Genes Immun 2009: 10 (Suppl 1): S74-84.
25. Kawasaki E, Awata T, Ikegami H et al. Genetic association between the interleukin-2 receptor-alpha gene and mode of onset of type 1 diabetes in the Japanese population. J Clin Endocrinol Metab 2009: 94: 947-52.
26. Qu HQ, Bradfield JP, Belisle A et al. The type I diabetes association of the IL2RA locus. Genes Immun 2009: 10 (Suppl 1): S42-8.
27. Klinker MW, Schiller JJ, Magnuson VL et al. Single-nucleotide polymorphisms in the IL2RA gene are associated with age at diagnosis in late-onset Finnish type 1 diabetes subjects. Immunogenetics 2010: 62: 101-7.
28. Sabbah E, Savola K, Ebeling T et al. Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes. Diabetes Care 2000: 23: 1326-32.
29. Hyttinen V, Kaprio J, Kinnunen L et al. Genetic liability of type 1 diabetes and the onset age among 22, 650 young Finnish twin pairs: a nationwide follow-up study. Diabetes 2003: 52: 1052.
30. Aminkeng F, Weets I, Van Autreve JE et al. Association of IL-2RA/CD25 with type 1 diabetes in the Belgian population. Hum Immunol 2010: 71: 1233-7.
31. Owen CJ, Kelly H, Eden JA, Merriman ME, Perace SH, Merriman TR. Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J Clin Endocrinol Metab 2007: 92: 1106-11.
32. Dendrou CA, Plagnol V, Fung E et al. Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource. Net Genet 2009: 41: 1011-5.
33. Kim HP, Imbert J, Leonard WJ. Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. Cytokine Growth Factor Rev 2006: 17: 349-66.
34. Rubin LA, Galli F, Greene WC, Nelson DL, Jay G. The molecular basis for the generation of the human soluble interleukin 2 receptor. Cytokine 1999: 2: 330-6.
35. Manoussakis MN, Papadopoulos GK, Drosos AA, Moutsopoulos HM. Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseases. Clin Immunol Immunopathol 1989: 50: 321-32.
36. Giordano C, Galluzzo A, Marco A et al. Increased soluble interleukin-2 receptor levels in the sera of type 1 diabetic patients. Diabetes Res 1988: 8: 135-8.
37. Gertner LA, Pfeifer MC, Albini C, Francis GL. Soluble interleukin 2 receptor levels in children with type I insulin-dependent diabetes mellitus. Ann Clin Lab Sci 1995: 25: 44-51.
38. Bouchard G, Garrigue-Antar L, Sole V et al. The exon-3-encoded domain of IL-15Ralpha contributes to IL-15 high-affinity binding and is crucial for the IL-15 antagonistic effect of soluble IL-15Ralpha. J Mol Biol 2008: 382: 1-12.
39. Maier LM, Anderson DE, Severson CA et al. Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses. J Immunol 2009: 182: 1541-7.
40. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004: 199: 971-9.
41. Tree TI, Roep BO, Peakman M. A mini meta-analysis of studies on CD4+CD25+ T cells in human type 1 diabetes: report of the Immunology of Diabetes Society T Cell Workshop. Ann N Y Acad Sci 2006: 1079: 9-18.
42. Kriegel MA, Lohman T, Gabler C, Blank N, Kalden JR, Lorenz HM. Defective suppressor function of human CD4+CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 2004: 199: 1285-91.